Publication | Open Access
Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts
31
Citations
22
References
2012
Year
The combination of sorafenib with cisplatin might be a promising treatment option for high risk or recurrent HB.
| Year | Citations | |
|---|---|---|
Page 1
Page 1